Loading
Life sciences · Journal article
International Immunopharmacology · September 12, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Chronic inflammation is a hallmark of obesity and its associated metabolic disorders. Adipose tissue macrophages (ATMs) play a crucial role in maintaining tissue homeostasis and orchestrating metabolic inflammation. Importantly, the regulation of proinflammatory gene translation is critical for macrophage activation, a process that has been closely linked to the onset of insulin resistance and type 2 diabetes. Histone deacetylase 3 (HDAC3) is a contributing factor of inflammatory gene expression; however, its precise role in modulating adipose tissue inflammation and type 2 diabetes remains poorly understood. This study demonstrates that metabolically stressed-induced HDAC3 mediates ATMs inflammation. HDAC3 deficiency in macrophages reduces adipose tissue macrophage infiltration and fibrosis, improves hyperglycemia, and reduced weight gain, adiposity in diet-induced obesity mice. HDAC3 deficiency mitigated the chronic inflammation and fibrosis in adipose tissue by suppressing inflammatory cytokine production via H3K4Me3/H3K27Ac-mediated chromatin remodeling. Mechanistically, growth differentiation factor 3 (GDF3) functions as a sensor of metabolic stress, interacts with HDAC3 through histone modification-mediated chromatin remodeling of inflammation genes. Critically, HDAC3 and GDF3 co-expression increased in adipose tissue/ATMs of obese humans, correlating positively with BMI, blood glucose, and proinflammatory gene levels. Our finding identifies HDAC3 as a molecular nexus connecting ATMs activation to systemic insulin resistance and type 2 diabetes. The GDF3-HDAC3 axis drives transcriptional reprogramming through H3K4Me3/H3K27Ac modifications, revealing a novel therapeutic target for obesity-associated metabolic disease.